This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Copyright © 2019 Med Learning Group. Built by Divigner. All Rights Reserved.
In the management of asthma, healthcare professionals are challenged with barriers that hinder the integration of evidence-based recommendations into clinical practice (figure). Additionally, patients should be assessed for potential barriers to treatment, including the economic, physical, mental, emotional, and social burden imposed by this condition (figure). Considerations of medication-related adverse events, which may be a barrier to continued treatment, should also be assessed, as well as potential comorbidities, drug interaction, and inhaler technique.1
To address these barriers specific steps need to be followed to incorporate clinical practice recommendations into effective patient care. Ideally, interventions should be applied at both the patient and healthcare provider levels, and where applicable, the healthcare system.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2024 update). Updated July 2024. https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf. Accessed July 25, 2024
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Copyright © 2019 Med Learning Group. Built by Divigner. All Rights Reserved.